Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Prostate Cancer

Free Subscription Articles published in Prostate Retrieve available abstracts of 272 articles: HTML format Text format

Single Articles

March 2010
1. RAIMONDI S , Mabrouk JB, Shatenstein B, Maisonneuve P, et al
   Diet and prostate cancer risk with specific focus on dairy products and dietary calcium: A case-control study.
   Prostate. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. SHANMUGAM R , Kusumanchi P, Cheng L, Crooks P, et al
   A water-soluble parthenolide analogue suppresses in vivo prostate cancer growth by targeting NFkappaB and generating reactive oxygen species.
   Prostate. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. LANGEBERG WJ , Tahir SA, Feng Z, Kwon EM, et al
   Association of caveolin-1 and -2 genetic variants and post-treatment serum caveolin-1 with prostate cancer risk and outcomes.
   Prostate. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   February 2010
4. MCKEITHEN D , Graham T, Chung LW, Odero-Marah V, et al
   Snail transcription factor regulates neuroendocrine differentiation in LNCaP prostate cancer cells.
   Prostate. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. HOLT SK , Kwon EM, Lin DW, Ostrander EA, et al
   Association of hepsin gene variants with prostate cancer risk and prognosis.
   Prostate. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. RHODES KE , Simons JW, Soule HR
   The Prostate Cancer Foundation 16th Annual Scientific Retreat: Meeting report.
   Prostate. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. HE H , Xu J, Nelson PS, Marshall FF, et al
   Differential expression of the alpha2 chain of the interleukin-13 receptor in metastatic human prostate cancer ARCaP(M) cells.
   Prostate. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. BUSCHEMEYER WC 3RD , Klink JC, Mavropoulos JC, Poulton SH, et al
   Effect of intermittent fasting with or without caloric restriction on prostate cancer growth and survival in SCID mice.
   Prostate. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. GILL JK , Wilkens LR, Pollak MN, Stanczyk FZ, et al
   Androgens, growth factors, and risk of prostate cancer: The Multiethnic Cohort.
   Prostate. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. BATTISTA MC , Guimond MO, Roberge C, Doueik AA, et al
    Inhibition of DHCR24/Seladin-1 impairs cellular homeostasis in prostate cancer.
    Prostate. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. YAO V , Berkman CE, Choi JK, O'Keefe DS, et al
    Expression of prostate-specific membrane antigen (PSMA), increases cell folate uptake and proliferation and suggests a novel role for PSMA in the uptake of the non-polyglutamated folate, folic acid.
    Prostate. 2010;70:305-16.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. PARIKH A , Childress C, Deitrick K, Lin Q, et al
    Statin-induced autophagy by inhibition of geranylgeranyl biosynthesis in prostate cancer PC3 cells.
    Prostate. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. SUIKKI HE , Kujala PM, Tammela TL, van Weerden WM, et al
    Genetic alterations and changes in expression of histone demethylases in prostate cancer.
    Prostate. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. EATON CL , Colombel M, van der Pluijm G, Cecchini M, et al
    Evaluation of the frequency of putative prostate cancer stem cells in primary and metastatic prostate cancer.
    Prostate. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. KOBAYASHI T , Shimizu Y, Terada N, Yamasaki T, et al
    Regulation of androgen receptor transactivity and mTOR-S6 kinase pathway by Rheb in prostate cancer cell proliferation.
    Prostate. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. THOMAS F , Holly JM, Persad R, Bahl A, et al
    Fibronectin confers survival against chemotherapeutic agents but not against radiotherapy in DU145 prostate cancer cells: Involvement of the insulin like growth factor-1 receptor.
    Prostate. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. FLAIG TW , Glode M, Gustafson D, van Bokhoven A, et al
    A study of high-dose oral silybin-phytosome followed by prostatectomy in patients with localized prostate cancer.
    Prostate. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2010
18. KARANIKOLAS BD , Figueiredo ML, Wu L
    Comprehensive evaluation of the role of EZH2 in the growth, invasion, and aggression of a panel of prostate cancer cell lines.
    Prostate. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. BERRUTI A , Bollito E, Cracco CM, Volante M, et al
    The prognostic role of immunohistochemical chromogranin a expression in prostate cancer patients is significantly modified by androgen-deprivation therapy.
    Prostate. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
20. PANDIT B , Gartel AL
    New potential anti-cancer agents synergize with bortezomib and ABT-737 against prostate cancer.
    Prostate. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. HILL KM , Kalifa S, Das JR, Bhatti T, et al
    The role of PI 3-kinase p110beta in AKT signally, cell survival, and proliferation in human prostate cancer cells.
    Prostate. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. WILLIAMS SA , Xu Y, De Marzo AM, Isaacs JT, et al
    Prostate-specific antigen (PSA) is activated by KLK2 in prostate cancer ex vivo models and in prostate-targeted PSA/KLK2 double transgenic mice.
    Prostate. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. CALVO A , Perez-Stable C, Segura V, Catena R, et al
    Molecular characterization of the Ggamma-globin-Tag transgenic mouse model of hormone refractory prostate cancer: Comparison to human prostate cancer.
    Prostate. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. ZHANG M , Siedow M, Saia G, Chakravarti A, et al
    Inhibition of p21-activated kinase 6 (PAK6) increases radiosensitivity of prostate cancer cells.
    Prostate. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. ZHANG X , Wu M, Xiao H, Lee MT, et al
    Methylation of a single intronic CpG mediates expression silencing of the PMP24 gene in prostate cancer.
    Prostate. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2009
26. LI Y , Malaeb BS, Li ZZ, Thompson MG, et al
    Telomerase enzyme inhibition (TEI) and cytolytic therapy in the management of androgen independent osseous metastatic prostate cancer.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. WELLS TS , Bukowinski AT, Smith TC, Smith B, et al
    Racial differences in prostate cancer risk remain among US servicemen with equal access to care.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. LUBAHN J , Berndt SI, Jin CH, Klim A, et al
    Association of CASP8 D302H polymorphism with reduced risk of aggressive prostate carcinoma.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. MAXEINER A , Adkins CB, Zhang Y, Taupitz M, et al
    Retrospective analysis of prostate cancer recurrence potential with tissue metabolomic profiles.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. AL-MAMGANI A , Lebesque JV, Heemsbergen WD, Tans L, et al
    Controversies in the treatment of high-risk prostate cancer-what is the optimal combination of hormonal therapy and radiotherapy: a review of literature.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. STEVENS VL , Ahn J, Sun J, Jacobs EJ, et al
    HNF1B and JAZF1 genes, diabetes, and prostate cancer risk.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. LAVIN MF , Clarke R, Gardiner RA
    Differential expression of PCA3 and BMCC1 in prostate cancer.
    Prostate. 2009;69:1713-4.
    PubMed     Text format     Related articles   
    
    
    November 2009
33. KORECKIJ TD , Hill C, Azure L, Nguyen H, et al
    Low dose, alternating electric current inhibits growth of prostate cancer.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. KRISTAL AR , Price DK, Till C, Schenk JM, et al
    Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: Results from the prostate cancer prevention trial.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. SHIOTA M , Yokomizo A, Masubuchi D, Tada Y, et al
    Tip60 promotes prostate cancer cell proliferation by translocation of androgen receptor into the nucleus.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. WOLF P , Freudenberg N, Buhler P, Alt K, et al
    Three conformational antibodies specific for different PSMA epitopes are promising diagnostic and therapeutic tools for prostate cancer.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. NANDANA S , Ellwood-Yen K, Sawyers C, Wills M, et al
    Hepsin cooperates with MYC in the progression of adenocarcinoma in a prostate cancer mouse model.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. RENDE M , Rambotti MG, Stabile AM, Pistilli A, et al
    Novel localization of low affinity NGF receptor (p75) in the stroma of prostate cancer and possible implication in neoplastic invasion: An immunohistochemical and ultracytochemical study.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. HE H , Yang X, Davidson AJ, Wu D, et al
    Progressive epithelial to mesenchymal transitions in ARCaP(E) prostate cancer cells during xenograft tumor formation and metastasis.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. CHEN M , Huang YC, Yang S, Hsu JM, et al
    Common variants at 8q24 are associated with prostate cancer risk in Taiwanese men.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. VANCLEAVE TT , Moore JH, Benford ML, Brock GN, et al
    Interaction among variant vascular endothelial growth factor (VEGF) and its receptor in relation to prostate cancer risk.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. HOOKER S , Hernandez W, Chen H, Robbins C, et al
    Replication of prostate cancer risk loci on 8q24, 11q13, 17q12, 19q33, and Xp11 in African Americans.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. QUERO L , Giocanti N, Hennequin C, Favaudon V, et al
    Antagonistic interaction between bicalutamide (Casodex(R)) and radiation in androgen-positive prostate cancer LNCaP cells.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. VUK-PAVLOVIC S , Bulur PA, Lin Y, Qin R, et al
    Immunosuppressive CD14(+)HLA-DR(low/-) monocytes in prostate cancer.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. MURAKAMI M , Ugai H, Belousova N, Pereboev A, et al
    Chimeric adenoviral vectors incorporating a fiber of human adenovirus 3 efficiently mediate gene transfer into prostate cancer cells.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. XU B , Feng NH, Li PC, Tao J, et al
    A functional polymorphism in Pre-miR-146a gene is associated with prostate cancer risk and mature miR-146a expression in vivo.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. ISHIKURA N , Kawata H, Nishimoto A, Nakamura R, et al
    Establishment and characterization of an androgen receptor-dependent, androgen-independent human prostate cancer cell line, LNCaP-CS10.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. SFANOS KS , Bruno TC, Meeker AK, De Marzo AM, et al
    Human prostate-infiltrating CD8+ T lymphocytes are oligoclonal and PD-1+.
    Prostate. 2009;69:1694-703.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. HE M , Vanaja DK, Karnes RJ, Young CY, et al
    Epigenetic regulation of Myc on retinoic acid receptor beta and PDLIM4 in RWPE1 cells.
    Prostate. 2009;69:1643-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. TAKATA Y , Morris JS, King IB, Kristal AR, et al
    Correlation between selenium concentrations and glutathione peroxidase activity in serum and human prostate tissue.
    Prostate. 2009;69:1635-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. VAN GILS MP , Hessels D, Peelen WP, Vergunst H, et al
    Preliminary evaluation of the effect of dutasteride on PCA3 in post-DRE urine sediments: a randomized, open-label, parallel-group pilot study.
    Prostate. 2009;69:1624-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
52. QIAN DZ , Rademacher BL, Pittsenbarger J, Huang CY, et al
    CCL2 is induced by chemotherapy and protects prostate cancer cells from docetaxel-induced cytotoxicity.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. ZHENG SL , Hsing AW, Sun J, Chu LW, et al
    Association of 17 prostate cancer susceptibility loci with prostate cancer risk in Chinese men.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. LEE HJ , Chattopadhyay S, Yoon WH, Bahk JY, et al
    Overexpression of hepatocyte nuclear factor-3alpha induces apoptosis through the upregulation and accumulation of cytoplasmic p53 in prostate cancer cells.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. MORRISSEY C , Lai JS, Brown LG, Wang YC, et al
    The expression of osteoclastogenesis-associated factors and osteoblast response to osteolytic prostate cancer cells.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. LEON CG , Locke JA, Adomat HH, Etinger SL, et al
    Alterations in cholesterol regulation contribute to the production of intratumoral androgens during progression to castration-resistant prostate cancer in a mouse xenograft model.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. MASON TE , Ricks-Santi L, Chen W, Apprey V, et al
    Association of CD14 variant with prostate cancer in African American men.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. NADIMINTY N , Dutt S, Tepper C, Gao AC, et al
    Microarray analysis reveals potential target genes of NF-kappaB2/p52 in LNCaP prostate cancer cells.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. MILON BC , Agyapong A, Bautista R, Costello LC, et al
    Ras responsive element binding protein-1 (RREB-1) down-regulates hZIP1 expression in prostate cancer cells.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. RUNDLE AG , Neugut AI
    Modeling the effects of obesity and weight gain on PSA velocity.
    Prostate. 2009;69:1573-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
61. SATO S , Takahashi S, Asamoto M, Naiki T, et al
    Tranilast suppresses prostate cancer growth and osteoclast differentiation in vivo and in vitro.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. TERADA N , Shimizu Y, Yoshida T, Maeno A, et al
    Antiandrogen withdrawal syndrome and alternative antiandrogen therapy associated with the W741C mutant androgen receptor in a novel prostate cancer xenograft.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. LOCKE JA , Guns ES, Lehman ML, Ettinger S, et al
    Arachidonic acid activation of intratumoral steroid synthesis during prostate cancer progression to castration resistance.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. WHITAKER HC , Warren AY, Eeles R, Kote-Jarai Z, et al
    The potential value of microseminoprotein-beta as a prostate cancer biomarker and therapeutic target.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. VANDER GRIEND DJ , D'Antonio J, Gurel B, Antony L, et al
    Cell-autonomous intracellular androgen receptor signaling drives the growth of human prostate cancer initiating cells.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. LIU X , Gomez-Pinillos A, Liu X, Johnson EM, et al
    Induction of bicalutamide sensitivity in prostate cancer cells by an epigenetic Puralpha-mediated decrease in androgen receptor levels.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. SHYR CR , Tsai MY, Yeh S, Kang HY, et al
    Tumor suppressor PAX6 functions as androgen receptor Co-repressor to inhibit prostate cancer growth.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. FURUKAWA J , Wraight CJ, Freier SM, Peralta E, et al
    Antisense oligonucleotide targeting of insulin-like growth factor-1 receptor (IGF-1R) in prostate cancer.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. FABBRI F , Brigliadori G, Carloni S, Ulivi P, et al
    Docetaxel-ST1481 sequence exerts a potent cytotoxic activity on hormone-resistant prostate cancer cells by reducing drug resistance-related gene expression.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. VAN DUIJN PW , Ziel-van der Made AC, van der Korput JA, Trapman J, et al
    PTEN-mediated G1 cell-cycle arrest in LNCaP prostate cancer cells is associated with altered expression of cell-cycle regulators.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. LAVENDER NA , Komolafe OO, Benford M, Brock G, et al
    No association between variant DNA repair genes and prostate cancer risk among men of African descent.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. BONKHOFF H , Berges R
    From pathogenesis to prevention of castration resistant prostate cancer.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. WANG C , Tao W, Chen Q, Hu H, et al
    SRD5A2 V89L polymorphism and prostate cancer risk: A meta-analysis.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. ISAHAYA E , Hara N, Nishiyama T, Hoshii T, et al
    Bone metabolic disorder in patients with prostate cancer receiving androgen deprivation therapy (ADT): impact of ADT on the growth hormone/insulin-like growth factor-1/parathyroid hormone axis.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. SALAGIERSKI M , Verhaegh GW, Jannink SA, Smit FP, et al
    Differential expression of PCA3 and its overlapping PRUNE2 transcript in prostate cancer.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. KOSAKA T , Miyajima A, Shirotake S, Kikuchi E, et al
    Ets-1 and hypoxia inducible factor-1alpha inhibition by angiotensin II type-1 receptor blockade in hormone-refractory prostate cancer.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. PORVASNIK S , Sakamoto N, Kusmartsev S, Eruslanov E, et al
    Effects of CXCR4 antagonist CTCE-9908 on prostate tumor growth.
    Prostate. 2009;69:1460-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. SHELFER L
    The alchemy of jargon: Etymologies of urologic neologisms. Number 5: oncology and its vocabulary.
    Prostate. 2009;69:1369-71.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. WANG W , Bergh A, Damber JE
    Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate.
    Prostate. 2009;69:1378-86.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. CHAMBERS KF , Bacon JR, Kemsley EK, Mills RD, et al
    Gene expression profile of primary prostate epithelial and stromal cells in response to sulforaphane or iberin exposure.
    Prostate. 2009;69:1411-21.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. ESSER KA , Harpole CE, Prins GS, Diamond AM, et al
    Physical activity reduces prostate carcinogenesis in a transgenic model.
    Prostate. 2009;69:1372-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. NONN L , Ananthanarayanan V, Gann PH
    Evidence for field cancerization of the prostate.
    Prostate. 2009;69:1470-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. MATTHEWS SB , Vielhauer GA, Manthe CA, Chaguturu VK, et al
    Characterization of a novel novobiocin analogue as a putative C-terminal inhibitor of heat shock protein 90 in prostate cancer cells.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. ELLINGER J , Kahl P, von der Gathen J, Rogenhofer S, et al
    Global levels of histone modifications predict prostate cancer recurrence.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. HUANG KT , Walker AM
    Long term increased expression of the short form 1b prolactin receptor in PC-3 human prostate cancer cells decreases cell growth and migration, and causes multiple changes in gene expression consistent with reduced invasive capacity.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. YOU B , Girard P, Paparel P, Freyer G, et al
    Prognostic value of modeled PSA clearance on biochemical relapse free survival after radical prostatectomy.
    Prostate. 2009;69:1325-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
87. MAVIS CK , Morey Kinney SR, Foster BA, Karpf AR, et al
    Expression level and DNA methylation status of glutathione-S-transferase genes in normal murine prostate and TRAMP tumors.
    Prostate. 2009;69:1312-24.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. LI Y , Mizokami A, Izumi K, Narimoto K, et al
    CTEN/tensin 4 expression induces sensitivity to paclitaxel in prostate cancer.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
89. HESSELS D , van Gils MP, van Hooij O, Jannink SA, et al
    Predictive value of PCA3 in urinary sediments in determining clinico-pathological characteristics of prostate cancer.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. KOCH P , Petri M, Paradowska A, Stenzinger A, et al
    PTPIP51 mRNA and protein expression in tissue microarrays and promoter methylation of benign prostate hyperplasia and prostate carcinoma.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. TANG CH , Lu ME
    Adiponectin increases motility of human prostate cancer cells via adipoR, p38, AMPK, and NF-kappaB pathways.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. NELIUS T , Filleur S
    PSA surge/flare-up in patients with castration-refractory prostate cancer during the initial phase of chemotherapy.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. BARADARAN N , Ahmadi H, Salem S, Lotfi M, et al
    The protective effect of diabetes mellitus against prostate cancer: Role of sex hormones.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. SCHMIDT LJ , Regan KM, Anderson SK, Sun Z, et al
    Effects of the 5 alpha-reductase inhibitor dutasteride on gene expression in prostate cancer xenografts.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. SARRATS A , Comet J, Tabares G, Ramirez M, et al
    Differential percentage of serum prostate-specific antigen subforms suggests a new way to improve prostate cancer diagnosis.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
96. LEVESQUE MH , El-Alfy M, Cusan L, Labrie F, et al
    Androgen receptor as a potential sign of prostate cancer metastasis.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. HARPER CE , Cook LM, Patel BB, Wang J, et al
    Genistein and resveratrol, alone and in combination, suppress prostate cancer in SV-40 tag rats.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
98. STURZU A , Echner H, Heckl S
    The lily-of-the-valley fragrance receptor-potential in prostate cancer imaging.
    Prostate. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
99. MABJEESH NJ , Amir S, Stenger A, Chen J, et al
    Detection of prostate specific transcripts in the peripheral blood during brachytherapy predicts postoperative PSA kinetics.
    Prostate. 2009;69:1235-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
100. OBAJIMI O , Keen JC, Melera PW
     Inhibition of de novo purine synthesis in human prostate cells results in ATP depletion, AMPK activation and induces senescence.
     Prostate. 2009;69:1206-21.
     PubMed     Text format     Related articles    Abstract available
     
     
     July 2009
101. GUZMAN-RAMIREZ N , Voller M, Wetterwald A, Germann M, et al
     In vitro propagation and characterization of neoplastic stem/progenitor-like cells from human prostate cancer tissue.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. SINGH SS , Mehedint DC, Ford OH 3rd, Jeyaraj DA, et al
     Comparison of ACINUS, caspase-3, and TUNEL as apoptotic markers in determination of tumor growth rates of clinically localized prostate cancer using image analysis.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. KIMURA T , Kiyota H, Nakata D, Masaki T, et al
     A novel androgen-dependent prostate cancer xenograft model derived from skin metastasis of a Japanese patient.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. POWER CA , Pwint H, Chan J, Cho J, et al
     A novel model of bone-metastatic prostate cancer in immunocompetent mice.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
105. ZOLOCHEVSKA O , Figueiredo ML
     Cell cycle regulator cdk2ap1 inhibits prostate cancer cell growth and modifies androgen-responsive pathway function.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
106. KURODA K , Liu H, Kim S, Guo M, et al
     Docetaxel down-regulates the expression of androgen receptor and prostate-specific antigen but not prostate-specific membrane antigen in prostate cancer cell lines: Implications for PSA surrogacy.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
107. CLEMENTI M , Sanchez C, Benitez DA, Contreras HR, et al
     Gonadotropin releasing hormone analogs induce apoptosis by extrinsic pathway involving p53 phosphorylation in primary cell cultures of human prostatic adenocarcinomas.
     Prostate. 2009;69:1025-33.
     PubMed     Text format     Related articles    Abstract available
     
     
     June 2009
108. XU J , Sun J, Kader AK, Lindstrom S, et al
     Estimation of absolute risk for prostate cancer using genetic markers and family history.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
109. PAL P , Xi H, Guha S, Sun G, et al
     Common variants in 8q24 are associated with risk for prostate cancer and tumor aggressiveness in men of European ancestry.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
110. FESTUCCIA C , Gravina GL, Biordi L, D'Ascenzo S, et al
     Effects of EGFR tyrosine kinase inhibitor erlotinib in prostate cancer cells in vitro.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
111. KIM MH , Fields J
     Translationally regulated C/EBPbeta isoform expression upregulates metastatic genes in hormone-independent prostate cancer cells.
     Prostate. 2009;69:1256.
     PubMed     Text format     Related articles   
     
     
     
112. ATTARD G , Rizzo S, Ledaki I, Clark J, et al
     A novel, spontaneously immortalized, human prostate cancer cell line, Bob, offers a unique model for pre-clinical prostate cancer studies.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
113. GIBBS TC , Rubio MV, Zhang Z, Xie Y, et al
     Signal transduction responses to lysophosphatidic acid and sphingosine 1-phosphate in human prostate cancer cells.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
114. GOODYEAR SM , Kheyfets SB, Garcia FU, Stearns ME, et al
     Role of the VEGFR3/VEGFD receptor axis in TGFbeta1 activation of primary prostate cell lines.
     Prostate. 2009;69:982-90.
     PubMed     Text format     Related articles    Abstract available
     
     
     
115. MURTOLA TJ , Pennanen P, Syvala H, Blauer M, et al
     Effects of simvastatin, acetylsalicylic acid, and rosiglitazone on proliferation of normal and cancerous prostate epithelial cells at therapeutic concentrations.
     Prostate. 2009;69:1017-23.
     PubMed     Text format     Related articles    Abstract available
     
     
     
116. SHIGEMURA K , Isotani S, Wang R, Fujisawa M, et al
     Soluble factors derived from stroma activated androgen receptor phosphorylation in human prostate LNCaP cells: roles of ERK/MAP kinase.
     Prostate. 2009;69:949-55.
     PubMed     Text format     Related articles    Abstract available
     
     
     
117. BOSE SK , Gibson W, Giri S, Nath N, et al
     Angiotensin II up-regulates PAX2 oncogene expression and activity in prostate cancer via the angiotensin II type I receptor.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
118. EMAMI KH , Brown LG, Pitts TE, Sun X, et al
     Nemo-like kinase induces apoptosis and inhibits androgen receptor signaling in prostate cancer cells.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
119. GATTI G , Quintar AA, Andreani V, Nicola JP, et al
     Expression of Toll-like receptor 4 in the prostate gland and its association with the severity of prostate cancer.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
120. SANCHEZ C , Mendoza P, Contreras HR, Vergara J, et al
     Expression of multidrug resistance proteins in prostate cancer is related with cell sensitivity to chemotherapeutic drugs.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
121. BRUSA D , Migliore E, Garetto S, Simone M, et al
     Immunogenicity of 56 degrees C and UVC-treated prostate cancer is associated with release of HSP70 and HMGB1 from necrotic cells.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
122. MONTORSI F , Alcaraz A, Desgrandchamps F, Hammerer P, et al
     A broader role for 5ARIs in prostate disease? Existing evidence and emerging benefits.
     Prostate. 2009;69:895-907.
     PubMed     Text format     Related articles    Abstract available
     
     
     
123. SVATEK RS , Jeldres C, Karakiewicz PI, Suardi N, et al
     Pre-treatment biomarker levels improve the accuracy of post-prostatectomy nomogram for prediction of biochemical recurrence.
     Prostate. 2009;69:886-94.
     PubMed     Text format     Related articles    Abstract available
     
     
     
124. KAWASAKI BT , Hurt EM, Kalathur M, Duhagon MA, et al
     Effects of the sesquiterpene lactone parthenolide on prostate tumor-initiating cells: An integrated molecular profiling approach.
     Prostate. 2009;69:827-37.
     PubMed     Text format     Related articles    Abstract available
     
     
     
125. KIM MH , Minton AZ, Agrawal V
     C/EBPbeta regulates metastatic gene expression and confers TNF-alpha resistance to prostate cancer cells.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
126. PETRIGLIANO FA , Virk MS, Liu N, Sugiyama O, et al
     Targeting of prostate cancer cells by a cytotoxic lentiviral vector containing a prostate stem cell antigen (PSCA) promoter.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     May 2009
127. TSUNODA T , Furusato B, Takashima Y, Ravulapalli S, et al
     The increased expression of periostin during early stages of prostate cancer and advanced stages of cancer stroma.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
128. NICOTERA TM , Schuster DP, Bourhim M, Chadha K, et al
     Regulation of PSA secretion and survival signaling by calcium-independent phopholipase A(2)beta in prostate cancer cells.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
129. SCHENK JM , Kristal AR, Neuhouser ML, Tangen CM, et al
     Serum adiponectin, C-peptide and leptin and risk of symptomatic benign prostatic hyperplasia: Results from the prostate cancer prevention trial.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
130. ZHAO Z , Liu J, Li S, Shen W, et al
     Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
131. PAYNE SR , Serth J, Schostak M, Kamradt J, et al
     DNA methylation biomarkers of prostate cancer: Confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detection.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
132. JOHANSSON M , McKay JD, Rinaldi S, Wiklund F, et al
     Genetic and plasma variation of insulin-like growth factor binding proteins in relation to prostate cancer incidence and survival.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
133. MORRISON C , Cheney R, Johnson CS, Smith G, et al
     Central quadrant procurement of radical prostatectomy specimens.
     Prostate. 2009;69:770-3.
     PubMed     Text format     Related articles    Abstract available
     
     
     
134. RICCIARDELLI C , Sakko AJ, Stahl J, Tilley WD, et al
     Prostatic chondroitin sulfate is increased in patients with metastatic disease but does not predict survival outcome.
     Prostate. 2009;69:761-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
135. GARDNER CD , Oelrich B, Liu JP, Feldman D, et al
     Prostatic soy isoflavone concentrations exceed serum levels after dietary supplementation.
     Prostate. 2009;69:719-26.
     PubMed     Text format     Related articles    Abstract available
     
     
     
136. YEH IT , Reddick RL, Kumar AP
     Malignancy arising in seminal vesicles in the transgenic adenocarcinoma of mouse prostate (TRAMP) model.
     Prostate. 2009;69:755-60.
     PubMed     Text format     Related articles    Abstract available
     
     
     
137. GOODYEAR SM , Amatangelo MD, Stearns ME
     Dysplasia of human prostate CD133(hi) sub-population in NOD-SCIDS is blocked by c-myc anti-sense.
     Prostate. 2009;69:689-98.
     PubMed     Text format     Related articles    Abstract available
     
     
     
138. RONQUIST KG , Ronquist G, Carlsson L, Larsson A, et al
     Human prostasomes contain chromosomal DNA.
     Prostate. 2009;69:737-43.
     PubMed     Text format     Related articles    Abstract available
     
     
     
139. RAVENNA L , Sale P, Di Vito M, Russo A, et al
     Up-regulation of the inflammatory-reparative phenotype in human prostate carcinoma.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
140. IZUMI K , Mizokami A, Li YQ, Narimoto K, et al
     Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
141. KADER AK , Sun J, Isaacs SD, Wiley KE, et al
     Individual and cumulative effect of prostate cancer risk-associated variants on clinicopathologic variables in 5,895 prostate cancer patients.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
142. LEMAN ES , Magheli A, Cannon GW, Mangold L, et al
     Analysis of a serum test for prostate cancer that detects a second epitope of EPCA-2.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
143. PANG B , Zhang H, Wang J, Chen WZ, et al
     Ubiquitous mitochondrial creatine kinase is overexpressed in the conditioned medium and the extract of LNCaP lineaged androgen independent cell lines and facilitates prostate cancer progression.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
144. VYKHOVANETS EV , Shukla S, MacLennan GT, Vykhovanets OV, et al
     Il-1 beta-induced post-transition effect of NF-kappaB provides time-dependent wave of signals for initial phase of intrapostatic inflammation.
     Prostate. 2009;69:633-43.
     PubMed     Text format     Related articles    Abstract available
     
     
     
145. LIU CM , Lo YC, Tai MH, Wu BN, et al
     Piperazine-designed alpha 1A/alpha 1D-adrenoceptor blocker KMUP-1 and doxazosin provide down-regulation of androgen receptor and PSA in prostatic LNCaP cells growth and specifically in xenografts.
     Prostate. 2009;69:610-23.
     PubMed     Text format     Related articles    Abstract available
     
     
     
146. LIU T , Wu LY, Choi JK, Berkman CE, et al
     In vitro targeted photodynamic therapy with a pyropheophorbide--a conjugated inhibitor of prostate-specific membrane antigen.
     Prostate. 2009;69:585-94.
     PubMed     Text format     Related articles    Abstract available
     
     
     
147. HANSEL DE , Nakayama M, Luo J, Abukhdeir AM, et al
     Shared TP53 gene mutation in morphologically and phenotypically distinct concurrent primary small cell neuroendocrine carcinoma and adenocarcinoma of the prostate.
     Prostate. 2009;69:603-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     April 2009
148. JANTSCHEFF P , Esser N, Graeser R, Ziroli V, et al
     Liposomal gemcitabine (GemLip)-efficient drug against hormone-refractory Du145 and PC-3 prostate cancer xenografts.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
149. KARSENTY G , Rocha J, Chevalier S, Scarlata E, et al
     Botulinum Toxin Type A Inhibits the Growth of LNCaP Human Prostate Cancer Cells In Vitro and In Vivo.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
150. JENNBACKEN K , Gustavsson H, Tesan T, Horn M, et al
     The prostatic environment suppresses growth of androgen-independent prostate cancer xenografts: An effect influenced by testosterone.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
151. LIU C , Hasegawa K, Russell SJ, Sadelain M, et al
     Prostate-specific membrane antigen retargeted measles virotherapy for the treatment of prostate cancer.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
152. MALINOWSKA K , Cavarretta IT, Susani M, Wrulich OA, et al
     Identification of micro-crystallin as an androgen-regulated gene in human prostate cancer.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
153. ISHKANIAN AS , Mallof CA, Ho J, Meng A, et al
     High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancer.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
154. YIN H , Lowery M, Glass J
     In prostate cancer C/EBPalpha promotes cell growth by the loss of interactions with CDK2, CDK4, and E2F and by activation of AKT.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
155. JAYADEVAPPA R , Chhatre S, Wein AJ, Malkowicz SB, et al
     Predictors of patient reported outcomes and cost of care in younger men with newly diagnosed prostate cancer.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
156. KELA I , Harmelin A, Waks T, Orr-Urtreger A, et al
     Interspecies comparison of prostate cancer gene-expression profiles reveals genes associated with aggressive tumors.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
157. ANANIAS HJ , van den Heuvel MC, Helfrich W, de Jong IJ, et al
     Expression of the gastrin-releasing peptide receptor, the prostate stem cell antigen and the prostate-specific membrane antigen in lymph node and bone metastases of prostate cancer.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
158. DOZMOROV MG , Hurst RE, Culkin DJ, Kropp BP, et al
     Unique patterns of molecular profiling between human prostate cancer LNCaP and PC-3 cells.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
159. SUN Y , Goodison S
     Optimizing molecular signatures for predicting prostate cancer recurrence.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
160. JOHN K , Ragavan N, Pratt MM, Singh PB, et al
     Quantification of phase I/II metabolizing enzyme gene expression and polycyclic aromatic hydrocarbon-DNA adduct levels in human prostate.
     Prostate. 2009;69:505-19.
     PubMed     Text format     Related articles    Abstract available
     
     
     
161. PARSONS JK , Saria EA, Nakayama M, Vessella RL, et al
     Comprehensive mutational analysis and mRNA isoform quantification of TP63 in normal and neoplastic human prostate cells.
     Prostate. 2009;69:559-69.
     PubMed     Text format     Related articles    Abstract available
     
     
     
162. MLCOCHOVA P , Barinka C, Tykvart J, Sacha P, et al
     Prostate-specific membrane antigen and its truncated form PSM'.
     Prostate. 2009;69:471-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     
163. KISS P , Eltoum IE, Suranyi P, Zeng H, et al
     Virtual in vivo biopsy map of early prostate neoplasm in TRAMP mice by MRI.
     Prostate. 2009;69:449-58.
     PubMed     Text format     Related articles    Abstract available
     
     
     March 2009
164. BENITEZ DA , Hermoso MA, Pozo-Guisado E, Fernandez-Salguero PM, et al
     Regulation of cell survival by resveratrol involves inhibition of NFkappaB-regulated gene expression in prostate cancer cells.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
165. ISAYEVA T , Moore LD, Chanda D, Chen D, et al
     Tumoristatic effects of endostatin in prostate cancer is dependent on androgen receptor status.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
166. MONSEF N , Soller M, Isaksson M, Abrahamsson PA, et al
     The expression of pluripotency marker Oct 3/4 in prostate cancer and benign prostate hyperplasia.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
167. FLEISCHMANN A , Schlomm T, Kollermann J, Sekulic N, et al
     Immunological microenvironment in prostate cancer: High mast cell densities are associated with favorable tumor characteristics and good prognosis.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
168. WANG MH , Helzlsouer KJ, Smith MW, Hoffman-Bolton JA, et al
     Association of IL10 and Other immune response- and obesity-related genes with prostate cancer in CLUE II.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
169. WATSON SK , Woolcock BW, Fee JN, Bainbridge TC, et al
     Minimum altered regions in early prostate cancer progression identified by high resolution whole genome tiling path BAC array comparative hybridization.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
170. ZHAO H , Peehl DM
     Tumor-promoting phenotype of CD90(hi) prostate cancer-associated fibroblasts.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
171. INOUE T , Maeno A, Talbot C Jr, Zeng Y, et al
     Purine-rich element binding protein (PUR) alpha induces endoplasmic reticulum stress response, and cell differentiation pathways in prostate cancer cells.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
172. FEYERABEND S , Stevanovic S, Gouttefangeas C, Wernet D, et al
     Novel multi-peptide vaccination in Hla-A2+ hormone sensitive patients with biochemical relapse of prostate cancer.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
173. KIM S , Lee JB, Lee GK, Chang J, et al
     Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
174. RAY AM , Zuhlke KA, Levin AM, Douglas JA, et al
     Sequence variation in the mitochondrial gene cytochrome c oxidase subunit I and prostate cancer in African American men.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
175. LOCKE JA , Fazli L, Adomat H, Smyl J, et al
     A novel communication role for CYP17A1 in the progression of castration-resistant prostate cancer.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
176. JARIWALA U , Cogan JP, Jia L, Frenkel B, et al
     Inhibition of AR-mediated transcription by binding of Oct1 to a motif enriched in AR-occupied regions.
     Prostate. 2009;69:392-400.
     PubMed     Text format     Related articles    Abstract available
     
     
     
177. SOTOMAYOR P , Godoy A, Smith GJ, Huss WJ, et al
     Oct4A is expressed by a subpopulation of prostate neuroendocrine cells.
     Prostate. 2009;69:401-10.
     PubMed     Text format     Related articles    Abstract available
     
     
     February 2009
178. MA C , Yoshioka M, Boivin A, Gan L, et al
     Atlas of dihydrotestosterone actions on the transcriptome of prostate in vivo.
     Prostate. 2009;69:293-316.
     PubMed     Text format     Related articles    Abstract available
     
     
     
179. BONORDEN MJ , Rogozina OP, Kluczny CM, Grossmann ME, et al
     Cross-sectional analysis of intermittent versus chronic caloric restriction in the TRAMP mouse.
     Prostate. 2009;69:317-26.
     PubMed     Text format     Related articles    Abstract available
     
     
     
180. HAFFNER J , Potiron E, Bouye S, Puech P, et al
     Peripheral zone prostate cancers: location and intraprostatic patterns of spread at histopathology.
     Prostate. 2009;69:276-82.
     PubMed     Text format     Related articles    Abstract available
     
     
     
181. YU X , Wang Y, Jiang M, Bierie B, et al
     Activation of beta-Catenin in mouse prostate causes HGPIN and continuous prostate growth after castration.
     Prostate. 2009;69:249-62.
     PubMed     Text format     Related articles    Abstract available
     
     
     
182. PALAPATTU GS , Wu C, Silvers CR, Martin HB, et al
     Selective expression of CD44, a putative prostate cancer stem cell marker, in neuroendocrine tumor cells of human prostate cancer.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
183. WIKSTROM P , Marusic J, Stattin P, Bergh A, et al
     Low stroma androgen receptor level in normal and tumor prostate tissue is related to poor outcome in prostate cancer patients.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
184. FERNANDEZ-MARTINEZ AB , Bajo AM, Sanchez-Chapado M, Prieto JC, et al
     Vasoactive intestinal peptide behaves as a pro-metastatic factor in human prostate cancer cells.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
185. WALTON TJ , Li G, McCulloch TA, Seth R, et al
     Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissue.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
186. HONG SK , Lee ST, Kim SS, Min KE, et al
     Significance of preoperative HbA1c level in patients with diabetes mellitus and clinically localized prostate cancer.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
187. DEEB D , Gao X, Jiang H, Dulchavsky SA, et al
     Oleanane Triterpenoid CDDO-Me inhibits growth and induces apoptosis in prostate cancer cells by independently targeting pro-survival Akt and mTOR.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
188. THOMAS F , Patel S, Holly JM, Persad R, et al
     Dihydrotestosterone sensitises LNCaP cells to death induced by epigallocatechin-3-Gallate (EGCG) or an IGF-I receptor inhibitor.
     Prostate. 2009;69:219-24.
     PubMed     Text format     Related articles    Abstract available
     
     
     
189. LEE SO , Chun JY, Nadiminty N, Lou W, et al
     Interleukin-4 activates androgen receptor through CBP/p300.
     Prostate. 2009;69:126-32.
     PubMed     Text format     Related articles    Abstract available
     
     
     
190. NARAYANAN NK , Nargi D, Horton L, Reddy BS, et al
     Inflammatory processes of prostate tissue microenvironment drive rat prostate carcinogenesis: preventive effects of celecoxib.
     Prostate. 2009;69:133-41.
     PubMed     Text format     Related articles    Abstract available
     
     
     January 2009
191. PEANT B , Diallo JS, Dufour F, Le Page C, et al
     Over-expression of IkappaB-kinase-epsilon (IKKepsilon/IKKi) induces secretion of inflammatory cytokines in prostate cancer cell lines.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
192. ZHANG X , Wang W, True LD, Vessella RL, et al
     Protease-activated receptor-1 is upregulated in reactive stroma of primary prostate cancer and bone metastasis.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
193. WAKCHOURE S , Swain TM, Hentunen TA, Bauskin AR, et al
     Expression of macrophage inhibitory cytokine-1 in prostate cancer bone metastases induces osteoclast activation and weight loss.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
194. LANDRISCINA M , Bagala C, Piscazzi A, Schinzari G, et al
     Nevirapine restores androgen signaling in hormone-refractory human prostate carcinoma cells both in vitro and in vivo.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
195. KOH YT , Gray A, Higgins SA, Hubby B, et al
     Androgen ablation augments prostate cancer vaccine immunogenicity only when applied after immunization.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
196. LEIN M , Miller K, Wirth M, Weissbach L, et al
     Bone turnover markers as predictive tools for skeletal complications in men with metastatic prostate cancer treated with zoledronic acid.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
197. TAKAHASHI S , Takeshita K, Seeni A, Sugiura S, et al
     Suppression of prostate cancer in a transgenic rat model via gamma-tocopherol activation of caspase signaling.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
198. DEHAAN AM , Wolters NM, Keller ET, Ignatoski KM, et al
     EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
199. MO Z , Gao Y, Cao Y, Gao F, et al
     An updating meta-analysis of the GSTM1, GSTT1, and GSTP1 polymorphisms and prostate cancer: A HuGE Review.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
200. THOMAS LN , Douglas RC, Rittmaster RS, Too CK, et al
     Overexpression of 5alpha-reductase type 1 increases sensitivity of prostate cancer cells to low concentrations of testosterone.
     Prostate. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
201. BOUYE S , Potiron E, Puech P, Leroy X, et al
     Transition zone and anterior stromal prostate cancers: zone of origin and intraprostatic patterns of spread at histopathology.
     Prostate. 2009;69:105-13.
     PubMed     Text format     Related articles    Abstract available
     
     
     
202. FORSBERG O , Carlsson B, Malmstrom PU, Ullenhag G, et al
     High frequency of prostate antigen-directed T cells in cancer patients compared to healthy age-matched individuals.
     Prostate. 2009;69:70-81.
     PubMed     Text format     Related articles    Abstract available
     
     
     
203. COX ME , Gleave ME, Zakikhani M, Bell RH, et al
     Insulin receptor expression by human prostate cancers.
     Prostate. 2009;69:33-40.
     PubMed     Text format     Related articles    Abstract available
     
     
     December 2008
204. WIKLUND F , Zheng SL, Sun J, Adami HO, et al
     Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
205. LU Q , Zhang J, Allison R, Gay H, et al
     Identification of extracellular delta-catenin accumulation for prostate cancer detection.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
206. CHU JH , Yu S, Hayward SW, Chan FL, et al
     Development of a three-dimensional culture model of prostatic epithelial cells and its use for the study of epithelial-mesenchymal transition and inhibition of PI3K pathway in prostate cancer.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
207. SAKAI Y , Goodison S, Kusmartsev S, Fletcher B, et al
     Bcl-2 mediated modulation of vascularization in prostate cancer xenografts.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
208. GROSS M , Ramirez C, Luthringer D, Nepomuceno E, et al
     Expression of androgen and estrogen related proteins in normal weight and obese prostate cancer patients.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
209. MINELLI A , Bellezza I, Tucci A, Rambotti MG, et al
     Differential involvement of reactive oxygen species and nucleoside transporters in cytotoxicity induced by two adenosine analogues in human prostate cancer cells.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
210. MURALIMANOHARAN SB , Kunnumakkara AB, Shylesh B, Kulkarni KH, et al
     Butanol fraction containing berberine or related compound from nexrutine(R) inhibits NFkappaB signaling and induces apoptosis in prostate cancer cells.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
211. TEZVAL H , Jurk S, Atschekzei F, Serth J, et al
     The involvement of altered corticotropin releasing factor receptor 2 expression in prostate cancer due to alteration of anti-angiogenic signaling pathways.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
212. SALINAS CA , Koopmeiners JS, Kwon EM, Fitzgerald L, et al
     Clinical utility of five genetic variants for predicting prostate cancer risk and mortality.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
213. NADIMINTY N , Chun JY, Lou W, Lin X, et al
     NF-kappaB2/p52 enhances androgen-independent growth of human LNCaP cells via protection from apoptotic cell death and cell cycle arrest induced by androgen-deprivation.
     Prostate. 2008;68:1725-33.
     PubMed     Text format     Related articles    Abstract available
     
     
     November 2008
214. LANGE EM , Beebe-Dimmer JL, Ray AM, Zuhlke KA, et al
     Genome-wide linkage scan for prostate cancer susceptibility from the university of michigan prostate cancer genetics project: Suggestive evidence for linkage at 16q23.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
215. CHENG Y , Kim JW, Liu W, Dunn TA, et al
     Genetic and epigenetic inactivation of TNFRSF10C in human prostate cancer.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
216. ZENG Y , Kakehi Y, Nouh MA, Tsunemori H, et al
     Gene expression profiles of lysophosphatidic acid-related molecules in the prostate: Relevance to prostate cancer and benign hyperplasia.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
217. YASUDA K , Nagakawa O, Akashi T, Fujiuchi Y, et al
     Serum active hepatocyte growth factor (AHGF) in benign prostatic disease and prostate cancer.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
218. LU Y , Zhang X, Beheshti B, Zhang J, et al
     Adenoviral-mediated pHyde Gene Transfer and Cisplatin Additively Inhibit Human Prostate Cancer Growth by Enhancing Apoptosis.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
219. THOMAS R , Kim MH
     A HIF-1alpha-dependent autocrine feedback loop promotes survival of serum-deprived prostate cancer cells.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
220. FLEISCHMANN A , Schobinger S, Schumacher M, Thalmann GN, et al
     Survival in surgically treated, nodal positive prostate cancer patients is predicted by histopathological characteristics of the primary tumor and its lymph node metastases.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
221. FESTUCCIA C , Gravina GL, Muzi P, Millimaggi D, et al
     Her2 crosstalks with TrkA in a subset of prostate cancer cells: Rationale for a guided dual treatment.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
222. KRANSE R , Roobol M, Schroder FH
     A graphical device to represent the outcomes of a logistic regression analysis.
     Prostate. 2008;68:1674-80.
     PubMed     Text format     Related articles    Abstract available
     
     
     
223. SCHWARZE SR , Lin EW, Christian PA, Gayheart DT, et al
     Intracellular death platform steps-in: targeting prostate tumors via endoplasmic reticulum (ER) apoptosis.
     Prostate. 2008;68:1615-23.
     PubMed     Text format     Related articles    Abstract available
     
     
     October 2008
224. SCHAFER SC , Pfnur M, Yerly S, Fandel TM, et al
     Cryopreservation of prostate cancer tissue during routine processing of fresh unfixed prostatectomy specimen: demonstration and validation of a new technique.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
225. BHAMRE S , Sahoo D, Tibshirani R, Dill DL, et al
     Temporal changes in gene expression induced by sulforaphane in human prostate cancer cells.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
226. MSAOUEL P , Iankov ID, Allen C, Morris JC, et al
     Engineered measles virus as a novel oncolytic therapy against prostate cancer.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
227. KNIGHT D , Peterson AC, Rini BI, Harlin H, et al
     The HLA-A2-restricted PSMA peptide LLHETDSAV is poorly immunogenic in patients with metastatic prostate cancer.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
228. STEPHAN C , Kahrs AM, Cammann H, Lein M, et al
     A [-2]proPSA-based artificial neural network significantly improves differentiation between prostate cancer and benign prostatic diseases.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
229. GRAHAM TR , Odero-Marah VA, Chung LW, Agrawal KC, et al
     PI3K/Akt-dependent transcriptional regulation and activation of BMP-2-Smad signaling by NF-kappaB in metastatic prostate cancer cells.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
230. KELLY MP , Lee ST, Lee FT, Smyth FE, et al
     Therapeutic efficacy of (177)Lu-CHX-A''-DTPA-hu3S193 radioimmunotherapy in prostate cancer is enhanced by EGFR inhibition or docetaxel chemotherapy.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
231. ARNOLD RS , Sun CQ, Richards JC, Grigoriev G, et al
     Mitochondrial DNA mutation stimulates prostate cancer growth in bone stromal environment.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
232. MUBIRU JN , Hubbard GB, Dick EJ Jr, Furman J, et al
     Nonhuman primates as models for studies of prostate specific antigen and prostatic diseases.
     Prostate. 2008;68:1546-54.
     PubMed     Text format     Related articles    Abstract available
     
     
     
233. MUMENTHALER SM , Rozengurt N, Livesay JC, Sabaghian A, et al
     Disruption of arginase II alters prostate tumor formation in TRAMP mice.
     Prostate. 2008;68:1561-9.
     PubMed     Text format     Related articles    Abstract available
     
     
     September 2008
234. YANG L , Gaikwad NW, Meza J, Cavalieri EL, et al
     Novel biomarkers for risk of prostate cancer: Results from a case-control study.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
235. MORI R , Xiong S, Wang Q, Tarabolous C, et al
     Gene profiling and pathway analysis of neuroendocrine transdifferentiated prostate cancer cells.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
236. KOBAYASHI M , Ishida H, Shindo T, Niwa SI, et al
     Molecular analysis of multifocal prostate cancer by comparative genomic hybridization.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
237. SCARIANO JK , Treat E, Alba F, Nelson H, et al
     The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancer.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
238. SHI XB , Xue L, Zou JX, Gandour-Edwards R, et al
     Prolonged androgen receptor loading onto chromatin and the efficient recruitment of p160 coactivators contribute to androgen-independent growth of prostate cancer cells.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
239. VAN NIEKERK CG , van der Laak JA, Borger ME, Huisman HJ, et al
     Computerized whole slide quantification shows increased microvascular density in pT2 prostate cancer as compared to normal prostate tissue.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
240. NAITO M , Itoh K, Komatsu N, Yamashita Y, et al
     Dexamethasone did not suppress immune boosting by personalized peptide vaccination for advanced prostate cancer patients.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
241. DIPAOLA RS , Dvorzhinski D, Thalasila A, Garikapaty V, et al
     Therapeutic starvation and autophagy in prostate cancer: A new paradigm for targeting metabolism in cancer therapy.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
242. VELTRI RW , Isharwal S, Miller MC, Epstein JI, et al
     Long-Term assessment of prostate cancer progression free survival: Evaluation of pathological parameters, nuclear shape and molecular biomarkers of pathogenesis.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
243. ROBBINS CM , Hernandez W, Ahaghotu C, Bennett J, et al
     Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     August 2008
244. WANG T , Alavian MR, Goel HL, Languino LR, et al
     Bicalutamide inhibits androgen-mediated adhesion of prostate cancer cells exposed to ionizing radiation.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
245. HEINRICH E , Schally AV, Buchholz S, Rick FG, et al
     Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
246. AALINKEEL R , Bindukumar B, Reynolds JL, Sykes DE, et al
     The dietary bioflavonoid, quercetin, selectively induces apoptosis of prostate cancer cells by down-regulating the expression of heat shock protein 90.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
247. CROSS NA , Fowles A, Reeves K, Jokonya N, et al
     Imaging the effects of castration on bone turnover and hormone-independent prostate cancer colonization of bone.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
248. RACLAW KA , Heemers HV, Kidd EM, Dehm SM, et al
     Induction of FLIP expression by androgens protects prostate cancer cells from TRAIL-mediated apoptosis.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
249. TERADA N , Tsuchiya N, Ma Z, Shimizu Y, et al
     Association of genetic polymorphisms at 8q24 with the risk of prostate cancer in a Japanese population.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
250. SAHA B , Kaur P, Tsao-Wei D, Naritoku WY, et al
     Unmethylated E-Cadherin gene expression is significantly associated with metastatic human prostate cancer cells in bone.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
251. STOCK DC , Groome PA, Siemens DR, Rohland SL, et al
     Effects of non-selective non-steroidal anti-inflammatory drugs on the aggressiveness of prostate cancer.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
252. TERANISHI JI , Ishiguro H, Hoshino K, Noguchi K, et al
     Evaluation of role of angiotensin III and aminopeptidases in prostate cancer cells.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
253. VAN GILS MP , Hessels D, Hulsbergen-van de Kaa CA, Witjes JA, et al
     Detailed analysis of histopathological parameters in radical prostatectomy specimens and PCA3 urine test results.
     Prostate. 2008;68:1215-22.
     PubMed     Text format     Related articles    Abstract available
     
     
     
254. KOISTINEN H , Wohlfahrt G, Mattsson JM, Wu P, et al
     Novel small molecule inhibitors for prostate-specific antigen.
     Prostate. 2008;68:1143-51.
     PubMed     Text format     Related articles    Abstract available
     
     
     
255. ZHANG J , Wilkinson JE, Gonit M, Keck R, et al
     Expression and sub-cellular localization of the CCAAT/enhancer binding protein alpha in relation to postnatal development and malignancy of the prostate.
     Prostate. 2008;68:1206-14.
     PubMed     Text format     Related articles    Abstract available
     
     
     
256. DOBOSY JR , Fu VX, Desotelle JA, Srinivasan R, et al
     A methyl-deficient diet modifies histone methylation and alters Igf2 and H19 repression in the prostate.
     Prostate. 2008;68:1187-95.
     PubMed     Text format     Related articles    Abstract available
     
     
     July 2008
257. REAGAN-SHAW S , Nihal M, Ahsan H, Mukhtar H, et al
     Combination of vitamin E and selenium causes an induction of apoptosis of human prostate cancer cells by enhancing Bax/Bcl-2 ratio.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
258. JOSSON S , Sung SY, Lao K, Chung LW, et al
     Radiation modulation of MicroRNA in prostate cancer cell lines.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
259. SHAIKH IA , Brown I, Schofield AC, Wahle KW, et al
     Docosahexaenoic acid enhances the efficacy of docetaxel in prostate cancer cells by modulation of apoptosis: The role of genes associated with the NF-kappaB pathway.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
260. SINGH P , Hallur G, Anchoori RK, Bakare O, et al
     Rational design of novel antiandrogens for neutralizing androgen receptor function in hormone refractory prostate cancer.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
261. HARAM KM , Peltier HJ, Lu B, Bhasin M, et al
     Gene expression profile of mouse prostate tumors reveals dysregulations in major biological processes and identifies potential murine targets for preclinical development of human prostate cancer therapy.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
262. NEUWIRT H , Arias MC, Puhr M, Hobisch A, et al
     Oligomeric proanthocyanidin complexes (OPC) exert anti-proliferative and pro-apoptotic effects on prostate cancer cells.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
263. BERG A , Bruland OS, Fossa SD, Nesland JM, et al
     Disseminated tumor cells in bone marrow following definitive radiotherapy for intermediate or high-risk prostate cancer.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
264. MORI R , Wang Q, Danenberg KD, Pinski JK, et al
     Both beta-actin and GAPDH are useful reference genes for normalization of quantitative RT-PCR in human FFPE tissue samples of prostate cancer.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
265. SHER DJ , Oh WK, Jacobus S, Regan MM, et al
     Relationship between serum adiponectin and prostate cancer grade.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
266. BINDUKUMAR B , Schwartz S, Aalinkeel R, Mahajan S, et al
     Proteomic profiling of the effect of prostate-specific antigen on prostate cancer cells.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
267. CHEN YC , Page JH, Chen R, Giovannucci E, et al
     Family history of prostate and breast cancer and the risk of prostate cancer in the PSA era.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
268. KAUR R , Yuan X, Lu ML, Balk SP, et al
     Increased PAK6 expression in prostate cancer and identification of PAK6 associated proteins.
     Prostate. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
269. TEICHERT F , Verschoyle RD, Greaves P, Edwards RE, et al
     Metabolic profiling of transgenic adenocarcinoma of mouse prostate (TRAMP) tissue by 1H-NMR analysis: evidence for unusual phospholipid metabolism.
     Prostate. 2008;68:1035-47.
     PubMed     Text format     Related articles    Abstract available
     
     
     
270. KURODA K , Horiguchi A, Asano T, Asano T, et al
     Prediction of lymphatic invasion by peritumoral lymphatic vessel density in prostate biopsy cores.
     Prostate. 2008;68:1057-63.
     PubMed     Text format     Related articles    Abstract available
     
     
     May 2008
271. KAWAI N , Futakuchi M, Yoshida T, Ito A, et al
     Effect of heat therapy using magnetic nanoparticles conjugated with cationic liposomes on prostate tumor in bone.
     Prostate. 2008;68:784-92.
     PubMed     Text format     Related articles    Abstract available
     
     
     
272. BERNOULLI J , Yatkin E, Laakso A, Anttinen M, et al
     Histopathological evidence for an association of inflammation with ductal pin-like lesions but not with ductal adenocarcinoma in the prostate of the noble rat.
     Prostate. 2008;68:728-39.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: